Archives - August 16, 2025

	Speedy Scripts, Slow Justice: When Medicines Arrive Before Regulation in India Licensing e-pharmacies strictly, enforcing real-time prescription authentication, introducing delivery tracking, and training riders like pharmacists could preserve safety without ditching speed.... Aug 16
	Credibility Meets Convenience: India’s GLP-1 Battleground Gets a KwikPen Revolution Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
	Breaking the Monopoly: Gland Pharma’s FDA-Cleared Injections Signal a New Era for Critical Care FDA-approved injectables adds credibility in Africa, Latin America, and beyond. The ripple effect may elevate Indian pharmaceutical manufacturing from “copycat” to “crown-standard.”... Aug 16
	Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way ... Aug 16
	NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration Essex Bio-Technology Limited is pleased to announce that a Biologics License Application (“BLA”) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal ... Aug 16
	Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access ... Aug 16
6 Stories found!